| |
| |
|
| Insider
Information: |
Russell Alan J |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,238 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,238 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Edgewise Therapeutics, Inc. |
EWTX |
|
2024-05-02 |
7,238 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2024-05-02 |
4 |
S |
$18.91 |
$29,802 |
D/D |
(1,576) |
7,238 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
8,814 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2023-12-26 |
4 |
S |
$9.33 |
$1,610,097 |
D/D |
(172,585) |
3,606 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2023-05-02 |
4 |
S |
$8.90 |
$14,266 |
D/D |
(1,602) |
176,191 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2023-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,208 |
177,793 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-15 |
4 |
AS |
$19.07 |
$9,155 |
D/D |
(479) |
0 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-12 |
4 |
AS |
$19.51 |
$167,074 |
D/D |
(8,562) |
479 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-11 |
4 |
AS |
$19.82 |
$384,238 |
D/D |
(19,276) |
9,041 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-10 |
4 |
AS |
$19.70 |
$243,170 |
D/D |
(12,326) |
28,317 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-09 |
4 |
AS |
$19.94 |
$594,306 |
D/D |
(29,576) |
40,643 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-08 |
4 |
AS |
$20.16 |
$181,824 |
D/D |
(9,017) |
70,219 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-05 |
4 |
AS |
$19.62 |
$255,907 |
D/D |
(13,042) |
79,236 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-04 |
4 |
AS |
$19.76 |
$146,092 |
D/D |
(7,392) |
92,278 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-03 |
4 |
AS |
$17.98 |
$476,096 |
D/D |
(26,184) |
99,670 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-02 |
4 |
AS |
$17.43 |
$305,360 |
D/D |
(17,519) |
125,854 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-11-01 |
4 |
AS |
$18.02 |
$8,454 |
D/D |
(469) |
143,373 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-15 |
4 |
AS |
$18.00 |
$25,966 |
D/D |
(1,433) |
143,842 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-14 |
4 |
AS |
$18.18 |
$104,517 |
D/D |
(5,749) |
145,275 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-11 |
4 |
AS |
$18.02 |
$22,885 |
D/D |
(1,270) |
151,024 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-08 |
4 |
AS |
$18.15 |
$107,121 |
D/D |
(5,902) |
152,294 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-07 |
4 |
AS |
$18.56 |
$241,614 |
D/D |
(13,018) |
158,196 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-06 |
4 |
AS |
$18.03 |
$38,007 |
D/D |
(2,108) |
171,214 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-05 |
4 |
S |
$18.26 |
$98,677 |
D/D |
(5,404) |
173,322 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-04 |
4 |
S |
$18.00 |
$1,800 |
D/D |
(100) |
178,726 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Chief Scientific Officer |
• • – |
2021-10-01 |
4 |
S |
$18.00 |
$4,932 |
D/D |
(274) |
178,826 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
